Commentary on „Gulati P, Chavan BS, Sidana A. Comparative efficacy of baclofen and lorazepam in the treatment of alcohol withdrawal syndrome (Indian Journal of Psychiatry, 2019)
Autoren: Parvesh Batra, Anirudh Bhushan & Neha Dhiman
(pp, 10.01.2020)
Struktur des Inhalts
Abstract im englischen Original
The study by Gulati et al., 2019 comparing baclofen and lorazepam in alcohol withdrawal syndrome (AWS) in line of finding safer alternatives for managing AWS is well desired. However, we would like to highlight a few methodological and ethical issues.
Link zu den bibliographischen Angaben des Kommentars auf PubMed
Link zum frei zugänglichen englischen Volltext
Die Autoren haben auf diesen Kommentar geantwortet.
